Literature DB >> 27928360

Bidirectional Synergistic Vergence.

Gokcen Gokce1, Cem Ozgonul2, Halil Huseyin Cagatay3, Metin Ekinci3, Osman Melih Ceylan4, Fatih Mehmet Mutlu5.   

Abstract

A 14-year-old boy presented with left ptosis and squint since his childhood. In primary position he had left hypotropia with ptosis (levator function 2 mm). With elevation of the right eye, the left eye depresses and adducts; with depression of the right eye, the left eye elevates and abducts. Forced duction test revealed no restrictive pattern. The synergistic divergence described in the literature was unidirectional and wholly compatible with inferior rectus co-contraction. But this case is bidirectional, and the aberrant upward movement cannot be explained by rectus muscle co-contraction. The two vertical rectus muscles show reciprocal misinnervation, or this effect could be coming from co-contraction of one of the oblique muscles for the movement in one direction.

Entities:  

Keywords:  Divergence; innervation; oblique muscle; oculomotor nerve; rectus muscle

Year:  2015        PMID: 27928360      PMCID: PMC5123172          DOI: 10.3109/01658107.2015.1056379

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  3 in total

1.  Misinnervation in the third nerve palsy: vertical synergistic divergence or consummate congenital bilateral asymmetrical Brown's syndrome with congenital ptosis?

Authors:  Pramod Kumar Pandey; Subhash Dadeya; Anupam Singh; Pankaj Vats; Neha Rathi; Sonal Dangta
Journal:  Indian J Ophthalmol       Date:  2010 Nov-Dec       Impact factor: 1.848

2.  Vertical synergistic divergence: to be or not to be, that is the quintessential question.

Authors:  Pramod Kumar Pandey; Pankaj Vats; Anupam Singh; Neha Rathi; Abhishek Sharma; Shagun Sood
Journal:  Indian J Ophthalmol       Date:  2013-02       Impact factor: 1.848

3.  Misinnervation in third nerve palsy: vertical synergistic divergence.

Authors:  Jitendra Jethani
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.